Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Supports PDUFA VIII Commitment Letter and…
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter:“For more…
Learn more
BIO Statement on Senate Reintroduction of the…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
Learn more
BIO International Convention Returns to San Diego…
20,000+ biotech leaders gather with a shared mission: to improve lives  SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Elects Paul Hastings as New Board Chair
June 11, 2021
New Officers Join BIO’s Governing Boards
BIO Takes on Health Equity in Clinical Trials
June 10, 2021
First-ever BIO Clinical Trial Diversity Summit will engage stakeholders to build a sustainable and equitable clinical development ecosystem
BIO Cheers Biden Announcement to Share 20 Million Doses of Vaccines with Developing Nations
May 18, 2021
"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE”…
BIO Extends Agreement with Avantor
May 10, 2021
Today, the Biotechnology Innovation Organization (BIO) announced an extension through June 2029 to its established agreement with Avantor. Through this agreement, members across North America have access to a broad…
Support of "TRIPS" Waiver Sets Dangerous Precedent
May 5, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the White House's support of waiving critical intellectual property rights for COVID-19…
Global “SHARE” Program for COVID could provide global protection against pandemic and create American jobs
May 4, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Joe Biden yesterday suggesting the establishment of a COVID Global Strategy for Harnessing Access Reaching Everyone (SHARE)…
BIO DIGITAL 2021 TO FEATURE WHO’s WHO IN PUBLIC HEALTH
May 3, 2021
Former CNN anchor Brooke Baldwin welcomes an all-star lineup including Albert Bourla, Francis Collins, Jennifer Doudna, Anthony Fauci, Sanjay Gupta, Richard Haass, Janet Woodcock, and a host of industry leaders
BIO's Dr. Michelle McMurry-Heath Comments on Passage of Washington State's Clean Fuel Standard
April 26, 2021
BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement following the passage of a clean fuel standard bill (HB 1091) in Washington state. "With the passage of HB 1091, Washington state is showing once again that climate…
H.R. 3 To Handicap Future Medical Innovation, Destroy Hope for Vulnerable Patients
April 22, 2021
Following the re-introduction of the H.R. 3 drug pricing legislation, Rich Masters -- Chief Public Affairs and Advocacy Officer of  the Biotechnology Innovation Organization (BIO) -- made the following remarks: "On behalf of BIO’s…
Proposed “TRIPS” Waiver Is the WRONG Way To Attack Global Access for Vaccines to Developing Countries
April 20, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), yesterday sent a letter to U.S. Trade Representative (USTR) Ambassador Katherine Tai sharing BIO perspectives regarding the proposed WTO “TRIPS waiver”…